Prior organ transplantation including allogenic stem cell transplantation
Prior allogenic stem cell or solid organ transplantation
Has undergone prior allogenic hematopoietic stem cell transplantation.
EXCLUSION - DURVALUMAB DRUG-SPECIFIC: History of allogenic organ transplantation.
Prior allogenic hematopoietic stem cell transplantation.
Prior organ transplantation including allogenic stem-cell transplantation
History of allogenic organ transplantation.
Prior organ transplantation including allogenic stem-cell transplantation within  months prior to planned enrollment.
Prior organ transplantation including allogenic stem-cell transplantation
History of allogenic organ transplantation that requires ongoing use of immunosuppressive agents is NOT permitted
Prior organ transplantation including allogenic stem-cell transplantation.
Prior organ transplantation including allogenic stem-cell transplantation
Prior organ transplantation including allogenic stem-cell transplantation
History of allogenic organ transplantation
Prior hematopoietic allogenic stem cell transplantation.
History of allogenic organ transplantation that requires use of immunosuppressive agents.
Have undergone prior allogenic bone marrow transplantation.
Prior organ transplantation including allogenic stem-cell transplantation.
History of allogenic organ transplantation
have undergone previous allogenic stem cell transplantation
History of bone marrow, stem cell, or allogenic organ transplantation
Eligible for allogenic stem cell transplantation.
Prior organ transplantation including allogenic stem cell transplantation.
Patients who have received allogenic stem cell transplants
Prior organ transplantation including allogenic stem-cell transplantation.
Previous allogenic stem cell transplantation.
Prior organ transplantation including allogenic stem-cell transplantation
Prior therapy with severely myelotoxic regimens, including autologous and allogenic stem cell transplantation
Previous allogenic stem cell or allogeneic bone marrow transplantation
Subject is not a candidate to undergo allogenic hematopoietic stem cell transplantation (HSCT).
Patients with prior allogenic transplants.